Acetaminophen is not classified as a teratogen. It does not cause structural birth defects, and major medical organizations including the American College of Obstetricians and Gynecologists (ACOG) still recommend it as the preferred pain reliever and fever reducer during pregnancy. That said, a growing body of research has raised questions about subtler effects on fetal development, particularly with prolonged use, which is why the answer is more nuanced than a simple yes or no.
What “Teratogen” Actually Means Here
A teratogen is a substance that causes structural malformations in a developing embryo or fetus. Think thalidomide, alcohol, or certain anti-seizure medications. By that strict definition, acetaminophen does not qualify. Decades of use and study have not linked it to cleft palate, heart defects, limb abnormalities, or any of the classic birth defects associated with known teratogens.
The FDA has stated that it has “not found clear evidence that appropriate use of acetaminophen during pregnancy causes adverse pregnancy, birth, neurobehavioral, or developmental outcomes.” ACOG goes further, reaffirming that acetaminophen “remains the analgesic and antipyretic of choice during pregnancy” and that “no change in clinical practice is warranted.”
Why the Question Keeps Coming Up
In 2021, a group of 91 scientists and clinicians published a consensus statement in Nature Reviews Endocrinology calling for more cautious use of acetaminophen during pregnancy. They did not call it a teratogen in the traditional sense but argued that prenatal exposure, especially prolonged use, could affect hormonal signaling and neurodevelopment in ways that warranted concern. They recommended that pregnant women use the lowest effective dose for the shortest possible time and skip it entirely when not medically needed.
This statement triggered a wave of media coverage and public anxiety. But it’s important to understand what the signatories were actually saying: not that acetaminophen is dangerous at normal doses, but that the research landscape had enough warning signals to justify precaution and further study. The major medical bodies reviewed the same evidence and reached a less alarming conclusion.
How Acetaminophen Reaches the Fetus
Acetaminophen crosses the placenta freely. Modeling studies have found that fetal blood concentrations are essentially the same as the mother’s, meaning whatever dose you take, your fetus is exposed to a comparable level. This is one reason researchers have focused on whether longer or higher-dose exposure windows might carry risks that occasional use does not.
The Neurodevelopmental Evidence
The most widely discussed concern involves ADHD and autism. A meta-analysis of six European cohorts found that children prenatally exposed to acetaminophen had roughly 19% higher odds of autism symptoms and 21% higher odds of ADHD symptoms. A large Swedish cohort study reported similar small increases: a hazard ratio of 1.05 for autism and 1.07 for ADHD at 10 years of age.
Those numbers sound concerning until you look at what they mean in absolute terms. In the Swedish study, the actual risk difference for ADHD was 0.21% at age 10. For autism, it was 0.09%. In practical terms, out of 1,000 children whose mothers used acetaminophen during pregnancy, roughly two additional children would receive an ADHD diagnosis compared to the unexposed group.
More importantly, these associations tend to weaken or disappear in sibling-controlled studies, which compare children born to the same mother where one pregnancy involved acetaminophen and another did not. In the Norwegian Mother, Father, and Child Cohort, long-term acetaminophen exposure (29 or more days) was initially linked to double the risk of ADHD. But when researchers compared siblings, the association dropped to nearly zero, with the hazard ratio falling from 2.02 to 1.06. This pattern strongly suggests that family-level factors like genetics, shared environment, or the underlying condition being treated are driving the association rather than the drug itself.
ACOG’s current position is that “the strongest and most methodologically rigorous studies show no evidence of causal association” between prenatal acetaminophen use and neurodevelopmental disorders.
Reproductive Development Concerns
A separate line of research has examined whether acetaminophen affects reproductive tract development in male fetuses. Three epidemiological studies have reported associations between maternal acetaminophen use and cryptorchidism (undescended testicles), though five others found no such link. No studies have found associations with hypospadias or differences in penile length.
The most specific finding involves anogenital distance, a physical marker of androgen exposure during a critical window of male development around weeks 8 to 14 of gestation. Two out of three studies found that acetaminophen exposure during this window was associated with a shorter anogenital distance in male infants. The concern is that acetaminophen may mildly suppress androgen signaling during a narrow developmental period. However, the inconsistency across studies means this remains an area of active investigation rather than an established risk.
The Asthma Question
Earlier research suggested that prenatal acetaminophen exposure might increase childhood asthma risk, possibly by lowering levels of a protective antioxidant in fetal lung tissue. However, a well-designed study of women where 69% used acetaminophen during pregnancy found no significant increase in asthma risk. In fact, use during both the first and third trimesters was associated with a reduced risk. There was no dose-response pattern, and even consumption exceeding 32 tablets per month did not increase risk. The biological plausibility for a link between acetaminophen and asthma remains weak, based primarily on lab findings that haven’t been confirmed in living systems.
Practical Guidance for Pregnancy
The consensus across medical organizations is straightforward: acetaminophen is still the safest over-the-counter pain and fever medication available during pregnancy. NSAIDs like ibuprofen carry their own risks, particularly in the third trimester when they can affect fetal blood circulation. Opioids have well-documented concerns. Leaving a high fever untreated also poses risks to fetal development.
The recommended approach during pregnancy is to keep daily intake under 3,000 mg, take it only when you genuinely need it, and use the lowest dose that works for the shortest stretch of time. Occasional use for a headache or fever is very different from daily use over weeks, and most of the concerning signals in the research involve prolonged, sustained exposure rather than typical intermittent use.
Non-drug options like exercise, acupuncture, and relaxation techniques are worth considering as a first line for chronic pain during pregnancy. When medication is needed, acetaminophen remains the go-to choice, not because it’s been proven risk-free in every conceivable scenario, but because it has the best safety profile of any available option.